NCT06197334 Gastro-intestinal Biopotential Recorder by Means of Surface ELEctrodes
| NCT ID | NCT06197334 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Central Hospital, Nancy, France |
| Condition | Crohn Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-02-18 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-02-18 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare the gastro-intestinal biopotentials recorded with a homemade device using surface electrodes placed on the abdomen in healthy volunteers, Crohn's disease patients without fibrosis, Crohn's disease patients with fibrosis and in functional gastrointestinal disorders (FGID) patients. The main question it aims to answer is: • Is there any differences in the gastro-intestinal biopotentials between the different populations under study? It aims to answer two secondary questions: * Are the gastro-intestinal biopotentials comparable to the Harvey-Bradshaw Index, MRI and biological data for patients with Crohn's disease? * Are the gastro-intestinal biopotentials comparable to Rome IV criteria for functional gastrointestinal disorders patients? Participants will undertake two recordings made with the device. The first one will last 1 hour and 30 minutes and will occurs while the participants are fasting. Then, the participants will eat a standardized meal. Finally, the second recording will take place after the meal ingestion and will last 1 hour and 30 minutes while the participants are in postprandial state.
Eligibility Criteria
Inclusion Criteria for all participants: * Person age \> 18 years * Person has been fasting for at least 12 hours * Person who has received full information on the organization of the research and has not objected to the use of this data. * Person affiliated to or beneficiary of a social security plan * Person informed about study organization and having signed the informed consent Inclusion Criteria for healthy volunteers : * Person has no history of chronic gastro-intestinal disease * Person has no acute of gastro-intestinal disease Inclusion Criteria for Crohn's disease patients without fibrosis : * Person is already diagnosed with Crohn's disease * Person has underwent during the last 6 months : * An MRI showing no fibrosis * A blood test for C-reactive protein and fecal calprotectine * A questionnaire to asses the Harvey-Bradshaw Index Inclusion Criteria for Crohn's disease patients with fibrosis : * Person is already diagnosed with Crohn's disease * Person has underwent during the last 6 months : * An MRI showing fibrosis * A blood test for C-reactive protein and fecal calprotectine * A questionnaire to asses the Harvey-Bradshaw Index Inclusion Criteria for functional gastrointestinal disorders patients : * Person is already diagnosed with functional gastrointestinal disorders * Person has underwent an evaluation of the Rome IV criteria Exclusion Criteria for all participants: * Person having a pacemaker * Person suffering from a sensory disorder making insensitive to pain on the skin * Person suffering from a mental or motor disorders creating uncontroled movements * Person being allergic to one or more component of the device * Person being allergic to : soy, dairy food, peanuts, wheat, nuts * Person having an history of gastro-intestinal surgery * Person suffering from injury or erythema on the abdominal skin * Person having a contagious potential (bacterial, fungal or viral) * Person being in menstruation period * Person suffering from urinary incontinence * Minor (not emancipated) * Person of legal age (subject to a legal protection measure) * Adult unable to give consent
Frequently Asked Questions
Who can join the NCT06197334 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Crohn Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06197334 currently recruiting?
Yes, NCT06197334 is actively recruiting participants. Visit ClinicalTrials.gov or contact Central Hospital, Nancy, France to inquire about joining.
Where is the NCT06197334 trial being conducted?
This trial is being conducted at Vandœuvre-lès-Nancy, France, Vandœuvre-lès-Nancy, France.
Who is sponsoring the NCT06197334 clinical trial?
NCT06197334 is sponsored by Central Hospital, Nancy, France. The trial plans to enroll 60 participants.